DA
DCF Advisers’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Hold |
51,350
| – | – | 0.58% | 45 |
|
|
2025
Q1 | $1.3M | Hold |
51,350
| – | – | 0.62% | 41 |
|
|
2024
Q4 | $1.36M | Buy |
51,350
+17,000
| +49% | +$451K | 0.66% | 43 |
|
|
2024
Q3 | $994K | Sell |
34,350
-900
| -3% | -$26K | 0.4% | 49 |
|
|
2024
Q2 | $986K | Buy |
35,250
+16,000
| +83% | +$448K | 0.51% | 50 |
|
|
2024
Q1 | $534K | Sell |
19,250
-2,250
| -10% | -$62.4K | 0.26% | 54 |
|
|
2023
Q4 | $619K | Sell |
21,500
-17,000
| -44% | -$489K | 0.34% | 47 |
|
|
2023
Q3 | $1.28M | Sell |
38,500
-1,750
| -4% | -$58K | 0.7% | 30 |
|
|
2023
Q2 | $1.48M | Hold |
40,250
| – | – | 0.78% | 29 |
|
|
2023
Q1 | $1.64M | Buy |
40,250
+4,000
| +11% | +$163K | 1.01% | 25 |
|
|
2022
Q4 | $1.86M | Hold |
36,250
| – | – | 1.26% | 20 |
|
|
2022
Q3 | $1.59M | Hold |
36,250
| – | – | 1.02% | 28 |
|
|
2022
Q2 | $1.9M | Sell |
36,250
-10,250
| -22% | -$538K | 1.13% | 29 |
|
|
2022
Q1 | $2.41M | Sell |
46,500
-18,500
| -28% | -$958K | 1.05% | 23 |
|
|
2021
Q4 | $3.84M | Hold |
65,000
| – | – | 1.56% | 15 |
|
|
2021
Q3 | $2.8M | Hold |
65,000
| – | – | 1.23% | 21 |
|
|
2021
Q2 | $2.55M | Buy |
65,000
+50,000
| +333% | +$1.96M | 0.9% | 26 |
|
|
2021
Q1 | $543K | Buy |
+15,000
| New | +$543K | 0.24% | 61 |
|